Aileron Overcoming Spirited Debate About Stapled Peptides
This article was originally published in The Pink Sheet Daily
Executive Summary
The new, promising class of drugs is rolling toward the clinic, but a respected research group recently thrust a stick in the spokes and prompted a call for wider access to the technology.